Literature DB >> 24741087

Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals.

Julia Nonnenmann1, Renate Stirner1, Julia Roider1, Maria C Jung2, Kathrin Schrödl1, Johannes R Bogner1, Rika Draenert3.   

Abstract

Myeloid-derived suppressor cells (MDSC) are immature myeloid cells with immunosuppressive function. Compared to the level in healthy controls (HC), no elevation of MDSC in chronic hepatitis C (cHEP-C) patients was found, and there was no difference in MDSC based on genotype or viral load (P > 0.25). Moreover, MDSC of cHEP-C patients inhibited CD8 T cell function as efficiently as MDSC of HC did. Since we detected neither quantitative nor qualitative differences in MDSC of cHEP-C patients relative to those of HC, we postulate that MDSC in peripheral blood are most likely not significant regarding immune dysfunction in cHEP-C.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24741087      PMCID: PMC4054423          DOI: 10.1128/JVI.00113-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.

Authors:  Robert S Tacke; Hai-Chon Lee; Celeste Goh; Jeremy Courtney; Stephen J Polyak; Hugo R Rosen; Young S Hahn
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

2.  Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses.

Authors:  N Rieber; C Gille; N Köstlin; I Schäfer; B Spring; M Ost; H Spieles; H A Kugel; M Pfeiffer; V Heininger; M Alkhaled; A Hector; L Mays; M Kormann; S Zundel; J Fuchs; R Handgretinger; C F Poets; D Hartl
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

Review 3.  Myeloid derived suppressor cells in human diseases.

Authors:  Tim F Greten; Michael P Manns; Firouzeh Korangy
Journal:  Int Immunopharmacol       Date:  2011-01-13       Impact factor: 4.932

4.  Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.

Authors:  Nikolaus Rieber; Alina Brand; Andreas Hector; Ute Graepler-Mainka; Michael Ost; Iris Schäfer; Irene Wecker; Davide Neri; Andreas Wirth; Lauren Mays; Sabine Zundel; Jörg Fuchs; Rupert Handgretinger; Martin Stern; Michael Hogardt; Gerd Döring; Joachim Riethmüller; Michael Kormann; Dominik Hartl
Journal:  J Immunol       Date:  2012-12-31       Impact factor: 5.422

5.  Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer.

Authors:  Sokratis Trellakis; Kirsten Bruderek; Jan Hütte; Motaz Elian; Thomas K Hoffmann; Stephan Lang; Sven Brandau
Journal:  Innate Immun       Date:  2012-11-16       Impact factor: 2.680

Review 6.  Myeloid-derived suppressor cells in cancer: recent progress and prospects.

Authors:  Yazan S Khaled; Basil J Ammori; Eyad Elkord
Journal:  Immunol Cell Biol       Date:  2013-06-25       Impact factor: 5.126

7.  Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients.

Authors:  Weiping Cai; Aiping Qin; Pengle Guo; Dehong Yan; Fengyu Hu; Qiong Yang; Min Xu; Yongshui Fu; Jie Zhou; Xiaoping Tang
Journal:  J Clin Immunol       Date:  2013-01-26       Impact factor: 8.317

Review 8.  Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.

Authors:  Juan-Ramón Larrubia; Selma Benito-Martínez; Joaquín Miquel; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

9.  A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Authors:  Bastian Hoechst; Lars A Ormandy; Matthias Ballmaier; Frank Lehner; Christine Krüger; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

10.  Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer.

Authors:  Chris P Verschoor; Jennie Johnstone; Jamie Millar; Michael G Dorrington; Mojtaba Habibagahi; Alina Lelic; Mark Loeb; Jonathan L Bramson; Dawn M E Bowdish
Journal:  J Leukoc Biol       Date:  2013-01-22       Impact factor: 4.962

View more
  8 in total

1.  Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.

Authors:  Ling Wang; Juan Zhao; Jun P Ren; Xiao Y Wu; Zheng D Morrison; Mohamed A Elgazzar; Shun B Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

2.  Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.

Authors:  Jun P Ren; Juan Zhao; Jun Dai; Jeddidiah W D Griffin; Ling Wang; Xiao Y Wu; Zheng D Morrison; Guang Y Li; Mohamed El Gazzar; Shun B Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-06-22       Impact factor: 7.397

Review 3.  The Role of Myeloid-Derived Suppressor Cells in Viral Infection.

Authors:  Megan A O'Connor; Jessica L Rastad; William R Green
Journal:  Viral Immunol       Date:  2017-01-04       Impact factor: 2.257

Review 4.  Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections.

Authors:  Anca Dorhoi; Nelita Du Plessis
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 5.  Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity.

Authors:  Graham Pawelec; Chris P Verschoor; Suzanne Ostrand-Rosenberg
Journal:  Front Immunol       Date:  2019-05-15       Impact factor: 7.561

6.  Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation.

Authors:  Sung-Eun Lee; Ji-Young Lim; Tae Woo Kim; Da-Bin Ryu; Sung Soo Park; Young-Woo Jeon; Jae-Ho Yoon; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Seok Lee; Seok-Goo Cho; Dong-Wook Kim; Jong Wook Lee; Chang-Ki Min
Journal:  J Immunother Cancer       Date:  2019-02-07       Impact factor: 13.751

7.  Kinetics of human myeloid-derived suppressor cells after blood draw.

Authors:  Eva Grützner; Renate Stirner; Lukas Arenz; Anastasia P Athanasoulia; Kathrin Schrödl; Carola Berking; Johannes R Bogner; Rika Draenert
Journal:  J Transl Med       Date:  2016-01-06       Impact factor: 5.531

8.  Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein.

Authors:  Ekaterina I Lesnova; Olga V Masalova; Kristina Yu Permyakova; Vyacheslav V Kozlov; Tatyana N Nikolaeva; Alexander V Pronin; Vladimir T Valuev-Elliston; Alexander V Ivanov; Alla A Kushch
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.